Evidence map›Paper›PMID 16424185›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2006

TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts.

Thomas B Thornley, Michael A Brehm, Thomas G Markees, Leonard D Shultz, John P Mordes, Raymond M Welsh, Aldo A Rossini, Dale L Greiner

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 127 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Sex as a biological variable: Mechanistic insights and clinical relevance in solid organ transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Review
  6. Methods to Study TLRs in Transplantation.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  7. Review
  8. Trained immunity in organ transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020
    Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Disruption of Transplant Tolerance by an "Incognito" Form of CD8 T Cell-Dependent Memory.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2017
    Article
  15. Article
  16. Review
  17. Regulatory T cell expressed MyD88 is critical for prolongation of allograft survival.Transplant international : official journal of the European Society for Organ Transplantation · 2016
    Article
  18. Innate immune mechanisms in transplant allograft vasculopathy.Current opinion in organ transplantation · 2016
    Review
  19. Article
  20. Innate allorecognition.Immunological reviews · 2014
    Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Thomas B ThornleyDivision of Diabetes, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Michael A Brehm
Thomas G Markees
Leonard D Shultz
John P Mordes
Raymond M Welsh
Aldo A Rossini
Dale L Greiner
University of Massachusetts Chan Medical School · USJackson Laboratory · US

Funding

Virology and Technology CoreP01AI046629 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GREINER, DALE LESLIE · 1999 to 2014
$19.1M
PILOT AND FEASIBILITY PROGRAMP30DK032520 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1986 to 2010
$14.6M
ROLE OF CBL AND PHOSPHATIDYLINOSITOL 3-KINASE IN CD40 SIGNALINGP01DK053006 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ROCK, KENNETH L · 1997 to 2007
$8.9M
REGULATION OF NATURAL KILLER CELLSR01CA034461 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WELSH, RAYMOND M · 1985 to 2005
$1.3M
NCI NIH HHS CA34461NCI NIH HHS R01 CA034461NIAID NIH HHS AI46629NIAID NIH HHS P01 AI046629NIDDK NIH HHS DK32520NIDDK NIH HHS DK53006NIDDK NIH HHS P01 DK053006NIDDK NIH HHS P30 DK032520
6 · The paper itself

Abstract

Costimulation blockade protocols are effective in prolonging allograft survival in animal models and are entering clinical trials, but how environmental perturbants affect graft survival remains largely unstudied. We used a costimulation blockade protocol consisting of a donor-specific transfusion and anti-CD154 mAb to address this question. We observed that lymphocytic choriomeningitis virus infection at the time of donor-specific transfusion and anti-CD154 mAb shortens allograft survival. Lymphocytic choriomeningitis virus 1) activates innate immunity, 2) induces allo-cross-reactive T cells, and 3) generates virus-specific responses, all of which may adversely affect allograft survival. To investigate the role of innate immunity, mice given costimulation blockade and skin allografts were coinjected with TLR2 (Pam3Cys), TLR3 (polyinosinic:polycytidylic acid), TLR4 (LPS), or TLR9 (CpG) agonists. Costimulation blockade prolonged skin allograft survival that was shortened after coinjection by TLR agonists. To investigate underlying mechanisms, we used "synchimeric" mice which circulate trace populations of anti-H2b transgenic alloreactive CD8+ T cells. In synchimeric mice treated with costimulation blockade, coadministration of all four TLR agonists prevented deletion of alloreactive CD8+ T cells and shortened skin allograft survival. These alloreactive CD8+ T cells 1) expressed the proliferation marker Ki-67, 2) up-regulated CD44, and 3) failed to undergo apoptosis. B6.TNFR2-/- and B6.IL-12R-/- mice treated with costimulation blockade plus LPS also exhibited short skin allograft survival whereas similarly treated B6.CD8alpha-/- and TLR4-/- mice exhibited prolonged allograft survival. We conclude that TLR signaling abrogates the effects of costimulation blockade by preventing alloreactive CD8+ T cell apoptosis through a mechanism not dependent on TNFR2 or IL-12R signaling.

Indexed as

Graft Enhancement, ImmunologicAnimalsAntibodies, MonoclonalApoptosisCD40 LigandCD8-Positive T-LymphocytesCell Line, TumorClonal DeletionFemaleGraft RejectionGrowth InhibitorsLipopolysaccharidesMiceMice, Inbred BALB CMice, Inbred C3HMice, Inbred C57BLAntibodies, MonoclonalCD40 LigandGrowth InhibitorsLipopolysaccharidesReceptors, InterleukinReceptors, Interleukin-12Receptors, Tumor Necrosis Factor, Type IITlr4 protein, mouseToll-Like Receptor 4Toll-Like Receptors

Identifiers

PMID16424185
PMCPMC3916149
OpenAlexW2131124022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.